Raymond James Financial Services Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-848
Closed -$304K 3299
2023
Q3
$304K Sell
848
-40
-5% -$14.3K ﹤0.01% 2636
2023
Q2
$337K Sell
888
-1,341
-60% -$508K ﹤0.01% 2581
2023
Q1
$1.07M Buy
2,229
+1,382
+163% +$662K ﹤0.01% 1861
2022
Q4
$356K Sell
847
-128
-13% -$53.8K ﹤0.01% 2471
2022
Q3
$407K Buy
975
+46
+5% +$19.2K ﹤0.01% 2365
2022
Q2
$460K Buy
929
+3
+0.3% +$1.49K ﹤0.01% 2329
2022
Q1
$522K Sell
926
-1,503
-62% -$847K ﹤0.01% 2352
2021
Q4
$1.84M Buy
2,429
+1,074
+79% +$811K ﹤0.01% 1600
2021
Q3
$1.01M Buy
1,355
+81
+6% +$60.4K ﹤0.01% 1949
2021
Q2
$821K Buy
1,274
+115
+10% +$74.1K ﹤0.01% 2074
2021
Q1
$662K Sell
1,159
-993
-46% -$567K ﹤0.01% 2105
2020
Q4
$1.25M Sell
2,152
-372
-15% -$217K ﹤0.01% 1565
2020
Q3
$1.3M Buy
2,524
+1,736
+220% +$895K ﹤0.01% 1385
2020
Q2
$356K Buy
788
+74
+10% +$33.4K ﹤0.01% 2133
2020
Q1
$250K Sell
714
-854
-54% -$299K ﹤0.01% 1941
2019
Q4
$580K Sell
1,568
-168
-10% -$62.1K ﹤0.01% 1870
2019
Q3
$578K Buy
1,736
+344
+25% +$115K ﹤0.01% 1812
2019
Q2
$435K Buy
1,392
+11
+0.8% +$3.44K ﹤0.01% 2011
2019
Q1
$422K Sell
1,381
-1,392
-50% -$425K ﹤0.01% 1997
2018
Q4
$644K Sell
2,773
-161
-5% -$37.4K ﹤0.01% 1512
2018
Q3
$918K Buy
2,934
+75
+3% +$23.5K ﹤0.01% 1517
2018
Q2
$825K Sell
2,859
-9
-0.3% -$2.6K ﹤0.01% 1541
2018
Q1
$717K Sell
2,868
-3,349
-54% -$837K ﹤0.01% 1514
2017
Q4
$1.48M Buy
6,217
+188
+3% +$44.9K 0.01% 1049
2017
Q3
$1.34M Sell
6,029
-335
-5% -$74.5K 0.01% 1122
2017
Q2
$1.44M Buy
6,364
+78
+1% +$17.6K 0.01% 1039
2017
Q1
$1.25M Buy
+6,286
New +$1.25M 0.01% 1052